SenzaGen AB (SENZA.ST)
SEK 7.0
(0.0%)
SEK 7.0
(0.0%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.91 SEK | 11.65% |
| 2022 | -1.03 SEK | 20.77% |
| 2021 | -1.30 SEK | -1.56% |
| 2020 | -1.28 SEK | 58.84% |
| 2019 | -3.11 SEK | -199.04% |
| 2018 | -1.04 SEK | 35.4% |
| 2017 | -1.61 SEK | -93.98% |
| 2016 | -0.83 SEK | -219.23% |
| 2015 | -0.26 SEK | -600.0% |
| 2014 | 0.05 SEK | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -0.30 SEK | -130.77% |
| 2024 Q1 | -0.13 SEK | 68.29% |
| 2023 Q4 | -0.41 SEK | -105.0% |
| 2023 Q2 | -0.51 SEK | -155.0% |
| 2023 FY | - SEK | 11.65% |
| 2023 Q1 | -0.20 SEK | 57.45% |
| 2023 Q3 | -0.20 SEK | 60.78% |
| 2022 Q2 | -0.56 SEK | -100.0% |
| 2022 Q4 | -0.47 SEK | -95.83% |
| 2022 FY | - SEK | 20.77% |
| 2022 Q1 | -0.28 SEK | 64.1% |
| 2022 Q3 | -0.24 SEK | 57.14% |
| 2021 Q2 | -0.65 SEK | -96.97% |
| 2021 FY | - SEK | -1.56% |
| 2021 Q4 | -0.78 SEK | -122.86% |
| 2021 Q3 | -0.35 SEK | 46.15% |
| 2021 Q1 | -0.33 SEK | 50.75% |
| 2020 Q1 | -0.30 SEK | 85.71% |
| 2020 FY | - SEK | 58.84% |
| 2020 Q4 | -0.67 SEK | -97.06% |
| 2020 Q3 | -0.34 SEK | 43.33% |
| 2020 Q2 | -0.60 SEK | -100.0% |
| 2019 Q3 | -1.05 SEK | -10.53% |
| 2019 Q2 | -0.95 SEK | -93.88% |
| 2019 Q1 | -0.49 SEK | -96.0% |
| 2019 FY | - SEK | -199.04% |
| 2019 Q4 | -2.10 SEK | -100.0% |
| 2018 FY | - SEK | 35.4% |
| 2018 Q1 | -0.28 SEK | 24.32% |
| 2018 Q2 | -0.28 SEK | 0.0% |
| 2018 Q3 | -0.25 SEK | 10.71% |
| 2018 Q4 | -0.25 SEK | 0.0% |
| 2017 Q2 | -0.38 SEK | 0.0% |
| 2017 FY | - SEK | -93.98% |
| 2017 Q3 | -0.37 SEK | 2.63% |
| 2017 Q1 | -0.38 SEK | -123.53% |
| 2017 Q4 | -0.37 SEK | 0.0% |
| 2016 FY | - SEK | -219.23% |
| 2016 Q3 | -0.17 SEK | 29.17% |
| 2016 Q2 | -0.24 SEK | 0.0% |
| 2016 Q1 | -0.24 SEK | 0.0% |
| 2016 Q4 | -0.17 SEK | 0.0% |
| 2015 FY | - SEK | -600.0% |
| 2014 FY | - SEK | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| AroCell AB (publ) | -0.26 SEK | -250.0% |
| Devyser Diagnostics AB (publ) | -3.31 SEK | 72.508% |
| Immunovia AB (publ) | -7.38 SEK | 87.669% |
| Prostatype Genomics AB (publ) | -0.24 SEK | -279.167% |
| Spermosens AB | -0.15 SEK | -506.667% |